NxThera Inc. has raised $1 million from the sale of equity and debt, according to documents filed with the Securities and Exchange Commission.
The start-up, based in St. Paul, is developing ways to treat enlarged prostates by using vapor injections and thermal energy to kill tissue.
CEO Robert Paulson formerly led Restore Medical Inc., a company based in Roseville that focused on treating sleep apnea. Medtronic Inc. (NYSE: MDT) purchased Restore in 2008 for nearly $30 million.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Last December, NxThera raised $3 million from investors, including Arboretum Ventures, Aberdare Ventures, GDN Holdings, an investment firm run by former Medtronic vice chairman Dr. Glen Nelson.